638 related articles for article (PubMed ID: 25187002)
21. Left Ventricular Reverse Remodeling With Biventricular Versus Right Ventricular Pacing in Patients With Atrioventricular Block and Heart Failure in the BLOCK HF Trial.
St John Sutton M; Plappert T; Adamson PB; Li P; Christman SA; Chung ES; Curtis AB
Circ Heart Fail; 2015 May; 8(3):510-8. PubMed ID: 25697851
[TBL] [Abstract][Full Text] [Related]
22. Chronic vagal stimulation for the treatment of low ejection fraction heart failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) randomized controlled trial.
Zannad F; De Ferrari GM; Tuinenburg AE; Wright D; Brugada J; Butter C; Klein H; Stolen C; Meyer S; Stein KM; Ramuzat A; Schubert B; Daum D; Neuzil P; Botman C; Castel MA; D'Onofrio A; Solomon SD; Wold N; Ruble SB
Eur Heart J; 2015 Feb; 36(7):425-33. PubMed ID: 25176942
[TBL] [Abstract][Full Text] [Related]
23. Vagus Nerve Stimulation Provides Multiyear Improvements in Autonomic Function and Cardiac Electrical Stability in the ANTHEM-HF Study.
Nearing BD; Anand IS; Libbus I; Dicarlo LA; Kenknight BH; Verrier RL
J Card Fail; 2021 Feb; 27(2):208-216. PubMed ID: 33049374
[TBL] [Abstract][Full Text] [Related]
24. Low-Level Vagus Nerve Stimulation Reverses Cardiac Dysfunction and Subcellular Calcium Handling in Rats With Post-Myocardial Infarction Heart Failure.
Zhang Y; Chen A; Song L; Li M; Luo Z; Zhang W; Chen Y; He B
Int Heart J; 2016 May; 57(3):350-5. PubMed ID: 27181040
[TBL] [Abstract][Full Text] [Related]
25. Rationale and study design of the NEuroCardiac TherApy foR Heart Failure Study: NECTAR-HF.
De Ferrari GM; Tuinenburg AE; Ruble S; Brugada J; Klein H; Butter C; Wright DJ; Schubert B; Solomon S; Meyer S; Stein K; Ramuzat A; Zannad F
Eur J Heart Fail; 2014 Jun; 16(6):692-9. PubMed ID: 24846173
[TBL] [Abstract][Full Text] [Related]
26. Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial.
Edelmann F; Musial-Bright L; Gelbrich G; Trippel T; Radenovic S; Wachter R; Inkrot S; Loncar G; Tahirovic E; Celic V; Veskovic J; Zdravkovic M; Lainscak M; Apostolović S; Neskovic AN; Pieske B; Düngen HD;
JACC Heart Fail; 2016 Feb; 4(2):140-149. PubMed ID: 26682793
[TBL] [Abstract][Full Text] [Related]
27. Optimal Titration Is Important to Maximize the Beneficial Effects of Vagal Nerve Stimulation in Chronic Heart Failure.
Nishizaki A; Sakamoto K; Saku K; Hosokawa K; Sakamoto T; Oga Y; Akashi T; Murayama Y; Kishi T; Ide T; Sunagawa K
J Card Fail; 2016 Aug; 22(8):631-8. PubMed ID: 27150492
[TBL] [Abstract][Full Text] [Related]
28. Long-term vagal stimulation for heart failure: Eighteen month results from the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) trial.
De Ferrari GM; Stolen C; Tuinenburg AE; Wright DJ; Brugada J; Butter C; Klein H; Neuzil P; Botman C; Castel MA; D'Onofrio A; de Borst GJ; Solomon S; Stein KM; Schubert B; Stalsberg K; Wold N; Ruble S; Zannad F
Int J Cardiol; 2017 Oct; 244():229-234. PubMed ID: 28663046
[TBL] [Abstract][Full Text] [Related]
29. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
[TBL] [Abstract][Full Text] [Related]
30. Vagus nerve stimulation mitigates intrinsic cardiac neuronal and adverse myocyte remodeling postmyocardial infarction.
Beaumont E; Southerland EM; Hardwick JC; Wright GL; Ryan S; Li Y; KenKnight BH; Armour JA; Ardell JL
Am J Physiol Heart Circ Physiol; 2015 Oct; 309(7):H1198-206. PubMed ID: 26276818
[TBL] [Abstract][Full Text] [Related]
31. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic responsiveness to vagus nerve stimulation in patients receiving beta-blockade for heart failure with reduced ejection fraction.
Dede E; Gregory DD; Ardell JL; Libbus I; DiCarlo LA; Premchand RK; Sharma K; Mittal S; Monteiro R; Anand IS; Düngen HD
Int J Cardiol Heart Vasc; 2021 Dec; 37():100888. PubMed ID: 34754899
[TBL] [Abstract][Full Text] [Related]
33. Changes in Loop Diuretic Dose and Outcome After Cardiac Resynchronization Therapy in Patients With Heart Failure and Reduced Left Ventricular Ejection Fractions.
Martens P; Verbrugge FH; Nijst P; Dupont M; Mullens W
Am J Cardiol; 2017 Jul; 120(2):267-273. PubMed ID: 28532770
[TBL] [Abstract][Full Text] [Related]
34. Non-pharmacologic autonomic neuromodulation for treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials.
Ahmed M; Nudy M; Bussa R; Weigel F; Naccarelli G; Maheshwari A
Trends Cardiovasc Med; 2024 Feb; 34(2):101-107. PubMed ID: 36202286
[TBL] [Abstract][Full Text] [Related]
35. Chronic vagus nerve stimulation is associated with multi-year improvement in intrinsic heart rate recovery and left ventricular ejection fraction in ANTHEM-HF.
Nearing BD; Libbus I; Carlson GM; Amurthur B; KenKnight BH; Verrier RL
Clin Auton Res; 2021 Jun; 31(3):453-462. PubMed ID: 33590355
[TBL] [Abstract][Full Text] [Related]
36. Clinical effects of long-term cardiac contractility modulation (CCM) in subjects with heart failure caused by left ventricular systolic dysfunction.
Müller D; Remppis A; Schauerte P; Schmidt-Schweda S; Burkhoff D; Rousso B; Gutterman D; Senges J; Hindricks G; Kuck KH
Clin Res Cardiol; 2017 Nov; 106(11):893-904. PubMed ID: 28685207
[TBL] [Abstract][Full Text] [Related]
37. Vagus nerve stimulation improves left ventricular function in a canine model of chronic heart failure.
Hamann JJ; Ruble SB; Stolen C; Wang M; Gupta RC; Rastogi S; Sabbah HN
Eur J Heart Fail; 2013 Dec; 15(12):1319-26. PubMed ID: 23883651
[TBL] [Abstract][Full Text] [Related]
38. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
[TBL] [Abstract][Full Text] [Related]
39. Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
J Am Coll Cardiol; 2020 Jul; 76(1):1-13. PubMed ID: 32616150
[TBL] [Abstract][Full Text] [Related]
40. Persistent Autonomic Engagement and Cardiac Control After Four or More Years of Autonomic Regulation Therapy Using Vagus Nerve Stimulation.
Libbus I; Premchand RK; Sharma K; Mittal S; Monteiro R; Amurthur B; KenKnight BH; DiCarlo LA; Anand IS
Front Physiol; 2022; 13():853617. PubMed ID: 35360224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
